Skip to main content

Skyworks: Fiscal Q1 Earnings Snapshot

IRVINE, Calif. (AP) — IRVINE, Calif. (AP) — Skyworks Solutions Inc. (SWKS) on Tuesday reported fiscal first-quarter profit of $79.2 million.

On a per-share basis, the Irvine, California-based company said it had profit of 53 cents. Earnings, adjusted for stock option expense and amortization costs, came to $1.54 per share.

The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $1.40 per share.

The chipmaker posted revenue of $1.04 billion in the period, which also beat Street forecasts. Eight analysts surveyed by Zacks expected $998.6 million.

For the current quarter ending in March, Skyworks expects its per-share earnings to be $1.04.

The company said it expects revenue in the range of $875 million to $925 million for the fiscal second quarter.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SWKS at https://www.zacks.com/ap/SWKS

Doctors question plan to screen military members for low testosterone

▶ Watch Video: Testosterone replacement therapy surges in popularity among men and women A day after Defense Secretary Pete Hegseth announced that U.S. service members over the age of 30 will be annually screened for "testosterone deficiency," doctors are expressing skepticism of the program and its goals. Hegseth said all service members over 30 will be screened as part of their regular health assessments, and that younger ones will have the option of being tested to ensure that they "have the right testosterone levels to operate at your absolute best." He said opting to receive testosterone replacement therapy will be voluntary. Hegseth has commented frequently on the physical standards of the military, connecting appearance and masculinity to combat readiness. Hegseth did not say what the new policy might mean for female service members, and other details have not yet been announced.Doctors flagged a range of concerns about the policy, which is likely to be costly to implement. National organizations including The Endocrine Society and the American College of Physicians recommend against general screenings for testosterone levels, which can fluctuate based on age, lifestyle and even the time of day."Testosterone in the normal range is not a performance drug," said Dr. Céline Gounder, CBS News medical correspondent and editor-at-large for public health at KFF Health News. "For a man whose level is genuinely low, replacement can help libido and mood a little. It has not been shown to sharpen thinking, fix fatigue, or make a healthy 30-year-old a better soldier."  "No link to how masculine they are or feel or look" Testosterone is a hormone naturally produced by the body. It helps maintain muscle and bone mass, and impacts mood and energy levels. It impacts libido and supports sperm production in men. But it isn't inherently linked to an increase in strength or capability, said Dr. Marcus Goncalves, director of the Holman Division of Endocrinology, Diabetes, and Metabolism at NYU Langone Health. "The normal range is from 270 to 900-plus. Putting people on that scale has no link to how masculine they are or feel or look. Somebody could be normal at 350, somebody could be normal at 650," Goncalves said. A number of factors can cause low testosterone, Goncalves said, including stress, poor sleep and overexertion. All of these may be common for service members, he said. Researchers have previously found that military training can impact testosterone levels. But when testosterone levels decrease due to lifestyle factors, the effect is "transient and reversible," and the hormone rebounds naturally when the situation changes, Goncalves said. There is no research to show that supplementing temporarily lower testosterone levels results in performance improvement, he added. Levels of testosterone naturally peak in early adulthood, around the 30- to 40-year-old range, before dropping by about 1% per year, Goncalves said. Low testosterone can result in fatigue, depression and poor concentration, Goncalves said. But young men have "very low risk of having low testosterone," he said, noting that the symptoms associated with low testosterone can also be caused by "20 other reasons.""When a man in his 30s or 40s has a low testosterone level, it's usually a signal of something else: extra weight, bad sleep, opioids, chronic stress," said Gounder. "That describes a lot of military life. Treating the cause is what works. Handing him a hormone treats the number and leaves the cause sitting there." Testing is complex — and expensive Because testosterone levels can vary so much, determining a person's levels can be difficult. It's recommended that people be tested in a narrow time window, between 8 and 10 a.m., Goncalves said, when testosterone is typically at its highest point. All reference ranges are calibrated to this time period, he said. Ideally, people should have fasted before undergoing the test. If a test shows low levels, it should be repeated at least once, he said. Diagnosing low testosterone tends to require multiple appointments and tests over the course of months. Gounder predicted that the blood draws alone would cost the military "tens of millions of dollars a year." Follow-up tests, treatment and monitoring will send the price tag soaring further, she said.   "There's no published analysis showing this is a good use of money, and that should matter for an administration concerned with waste, fraud and abuse," Gounder added. "The Endocrine Society looked at exactly this question, whether you should screen men for low testosterone, and concluded you shouldn't. So the military is about to spend real dollars, at scale, on a program the science says isn't worth doing." Risks of testosterone replacement therapy Testosterone replacement therapy uses anabolic steroids to increase testosterone levels. The steroids can be administered via injection, oral medicine or with a topical gel or patch. A vial of testosterone cypionate injection. Carolyn Kaster / AP
Read Next Story